Marked Reduction in 28-day Mortality Among Elderly Patients with Severe Community-acquired Pneumonia: Post Hoc Analysis of a Large Randomized Controlled Trial

BACKGROUND: There were few studies on the case mortality of severe community-acquired pneumonia (CAP) in elderly people. Improved outcomes with XueBiJing (XBJ) injection vs placebo have been shown in overall trial populations. We investigated the efficacy and safety of XBJ vs placebo in subjects wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yan, Zhang, Chi, Li, Chengyu, Bai, Chunxue, Shang, Hongcai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665517/
https://www.ncbi.nlm.nih.gov/pubmed/33204076
http://dx.doi.org/10.2147/CIA.S268140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665517/
https://www.ncbi.nlm.nih.gov/pubmed/33204076
http://dx.doi.org/10.2147/CIA.S268140

Ejemplares similares